Cargando…
Integrated genomic and transcriptomic analysis suggests KRT18 mutation and MTAP are key genetic alterations related to the prognosis between astrocytoma and glioblastoma
BACKGROUND: Astrocytoma and glioblastoma (GBM) are the two main subtypes of glioma, with the 2016 World Health Organization Classification of Tumors of the Central Nervous System (CNS WHO) classifying them into different grades. GBM is the most malignant among all CNS tumors with a 5-year survival r...
Autores principales: | Li, Zhiyong, Jin, Yinghui, Zou, Qingping, Shi, Xiaofeng, Wu, Qianchao, Lin, Zhiying, He, Qun, Huang, Guanglong, Qi, Songtao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8106028/ https://www.ncbi.nlm.nih.gov/pubmed/33987411 http://dx.doi.org/10.21037/atm-21-1317 |
Ejemplares similares
-
MTAP loss: a possible therapeutic approach for glioblastoma
por: Patro, C. Pawan K., et al.
Publicado: (2022) -
Homozygous MTAP deletion in primary human glioblastoma is not associated with elevation of methylthioadenosine
por: Barekatain, Yasaman, et al.
Publicado: (2021) -
MTAP: The Motif Tool Assessment Platform
por: Quest, Daniel, et al.
Publicado: (2008) -
Deletion of Dinucleotide Repeat (Δ14 Allele) in the Methylthioadenosine Phosphorylase (MTAP) Promoter and the Allelotype of MTAP Promoter in the Japanese Population
por: Kadariya, Yuwaraj, et al.
Publicado: (2002) -
Distinct aneuploid evolution of astrocytoma and glioblastoma during recurrence
por: Zhang, Jinsen, et al.
Publicado: (2023)